1. Home
  2. ATLX vs ADVM Comparison

ATLX vs ADVM Comparison

Compare ATLX & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATLX
  • ADVM
  • Stock Information
  • Founded
  • ATLX 2011
  • ADVM 2006
  • Country
  • ATLX Brazil
  • ADVM United States
  • Employees
  • ATLX N/A
  • ADVM N/A
  • Industry
  • ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATLX Industrials
  • ADVM Health Care
  • Exchange
  • ATLX Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • ATLX 101.9M
  • ADVM 119.6M
  • IPO Year
  • ATLX N/A
  • ADVM 2014
  • Fundamental
  • Price
  • ATLX $6.90
  • ADVM $4.33
  • Analyst Decision
  • ATLX Strong Buy
  • ADVM Strong Buy
  • Analyst Count
  • ATLX 3
  • ADVM 6
  • Target Price
  • ATLX $33.17
  • ADVM $27.83
  • AVG Volume (30 Days)
  • ATLX 85.6K
  • ADVM 211.3K
  • Earning Date
  • ATLX 11-08-2024
  • ADVM 11-04-2024
  • Dividend Yield
  • ATLX N/A
  • ADVM N/A
  • EPS Growth
  • ATLX N/A
  • ADVM N/A
  • EPS
  • ATLX N/A
  • ADVM N/A
  • Revenue
  • ATLX $543,657.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • ATLX N/A
  • ADVM N/A
  • Revenue Next Year
  • ATLX $8,777.97
  • ADVM $1,342.84
  • P/E Ratio
  • ATLX N/A
  • ADVM N/A
  • Revenue Growth
  • ATLX N/A
  • ADVM N/A
  • 52 Week Low
  • ATLX $6.12
  • ADVM $4.01
  • 52 Week High
  • ATLX $26.24
  • ADVM $29.70
  • Technical
  • Relative Strength Index (RSI)
  • ATLX 48.46
  • ADVM 36.50
  • Support Level
  • ATLX $6.80
  • ADVM $4.20
  • Resistance Level
  • ATLX $7.25
  • ADVM $4.78
  • Average True Range (ATR)
  • ATLX 0.45
  • ADVM 0.32
  • MACD
  • ATLX 0.05
  • ADVM 0.03
  • Stochastic Oscillator
  • ATLX 37.23
  • ADVM 28.07

About ATLX Atlas Lithium Corporation

Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. They intend to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: